glp-1 and botox The Face Effect of Weight Loss Aesthetic restoration following GLP-1 agonist–induced

SAN DIEGO, March 25, 2025 /PRNewswire/ FuturHealth, a leading provider of personalized weight-loss solutions, today announced the launch of Affirm (NASDAQ: AFRM), the payment network that empowers consumers and []

But Lilly is hitting a bigger market

Master impurity profiling, peptide separation, and structural characterization of semaglutide and tirzepatide

Teladoc (NYSE: TDOC), the multi-billion dollar market leader in telemedicine, has agreed to purchase Livongo (NDAQ: LVGO), the multi-billion dollar market leader in remote patient monitoring for $18.5 billion, creating the markets first $38 billion full-stack virtual health company.

In Metabolic Dysfunction-Associated Steatotic Liver Disease, GLP-1 RAs and GIP/GLP-1 RAs demonstrate marked histological improvements

$Hims & Hers Health (HIMS.US)$ With the FDA launching a green list initiative to block illegal or unverified GLP-1 drug ingredients from entering the U.S., companies like Hims & Hers Health (HIMS) may stand to benefit